The emerging burden of heart failure in adults with congenital heart disease

by Christopher J. Rush, John G.F. Cleland, Gruschen Veldtman
Published 2021-08-01

Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study

by Rosita Zakeri, Ann D. Morgan, Varun Sundaram, Chloe Bloom, John G. F. Cleland, Jennifer K. Quint
Published 2021-08-01

Home Telemonitoring reduces hospitalization for Heart Failure in an NHS service: a Propensity-Matched Analysis

by Yan Zhang, Chandrasekhar Kambhampati, John G.F. Cleland, Jennifer Caffarel, Harald Reiter, Kevin Goode, Riet Dierckx, Darryl Davis
Published 2013-11-01

Home Telemonitoring reduces hospitalization for Heart Failure in an NHS service: a Propensity-Matched Analysis

by Yan Zhang, Chandrasekhar Kambhampati, John G.F. Cleland, Jennifer Caffarel, Harald Reiter, Kevin Goode, Riet Dierckx, Darryl Davis
Published 2013-11-01

A comparison of non‐invasive methods of measuring body composition in patients with heart failure: a report from SICA‐HF

by Parin Shah, Alexandra A.I. Abel, Vennela Boyalla, Pierpaolo Pellicori, Anna Kallvikbacka‐Bennett, Shirley Sze, John G.F. Cleland, Andrew L. Clark
Published 2021-10-01

A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial

by Vasiliki Papageorgiou, Kathryn Jones, Brian P. Halliday, Richard Mindham, Jane Bruton, Rebecca Wassall, John G.F. Cleland, Sanjay K. Prasad, Helen Ward
Published 2021-10-01

Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies

by Ana Jorbenadze, Marat Fudim, Felix Mahfoud, Phillip B. Adamson, Tarek Bekfani, Rolf Wachter, Horst Sievert, Piotr P. Ponikowski, John G. F. Cleland, Stefan D. Anker
Published 2021-08-01

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin

by Ahmed Mohamed Abuosa, Ayman Hassan Elshiekh, Kahekashan Qureshi, Mohammed Burhan Abrar, Mona A. Kholeif, Abdulhalim Jamal Kinsara, Abdulwahab Andejani, Adel H. Ahmed, John G.F. Cleland
Published 2018-12-01

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

by Erik Tandberg Askevold, Lars Gullestad, Ståle Nymo, John Kjekshus, Arne Yndestad, Roberto Latini, John G F Cleland, John J V McMurray, Pål Aukrust, Thor Ueland
Published 2015-01-01

Muscle wasting as an independent predictor of survival in patients with chronic heart failure

by Stephan vonHaehling, Tania Garfias Macedo, Miroslava Valentova, Markus S. Anker, Nicole Ebner, Tarek Bekfani, Helge Haarmann, Joerg C. Schefold, Mitja Lainscak, John G. F. Cleland, Wolfram Doehner, Gerd Hasenfuss, Stefan D. Anker
Published 2020-10-01

Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure

by Kevin Damman, Mattia A. E. Valente, Dirk J. van Veldhuisen, John G. F. Cleland, Christopher M. O’Connor, Marco Metra, Piotr Ponikowski, Gad Cotter, Beth Davison, Michael M. Givertz, Daniel M. Bloomfield, Hans L. Hillege, Adriaan A. Voors
Published 2017-07-01

Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo‐controlled trial

by Miriam J. Johnson, Sarah Cockayne, David C. Currow, Kerry Bell, Kate Hicks, Caroline Fairhurst, Rhian Gabe, David Torgerson, Laura Jefferson, Stephen Oxberry, Justin Ghosh, Karen J. Hogg, Jeremy Murphy, Victoria Allgar, John G.F. Cleland, Andrew L. Clark
Published 2019-12-01

Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort...

by Jasper Tromp, Sahiddah Bamadhaj, John G F Cleland, Christiane E Angermann, Ulf Dahlstrom, Wouter Ouwerkerk, Wan Ting Tay, Kenneth Dickstein, Georg Ertl, Mahmoud Hassanein, Sergio V Perrone, Mathieu Ghadanfar, Anja Schweizer, Achim Obergfell, Carolyn SP Lam, Gerasimos Filippatos, Sean P Collins
Published 2020-08-01

Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial

by Job A. J. Verdonschot, João Pedro Ferreira, Pierpaolo Pellicori, Hans-Peter Brunner-La Rocca, Andrew L. Clark, Franco Cosmi, Joe Cuthbert, Nicolas Girerd, Beatrice Mariottoni, Johannes Petutschnigg, Patrick Rossignol, John G. F. Cleland, Faiez Zannad, Stephane R. B. Heymans, HOMAGE “Heart Omics in AGEing” consortium
Published 2021-08-01

Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening

by John G F Cleland, Naveed Sattar, Pierpaolo Pellicori, Paul Welsh, Srinivasa Vittal Katikireddi, Jill P Pell, Frederick K Ho, Stamatina Iliodromiti, Stuart Robert Gray, Carlos Celis-Morales, Jason Martin Regnald Gill, James Boyle, Lyn D Ferguson, John Forbes, Robert Lindsay, Jana J Anderson, Claire E Welsh
Published 2021-08-01

2016 ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE

by Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker, Héctor Bueno, John G. F. Cleland, Andrew J. S . Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A. Jankowska, Mariell Jessup, Cecilia Linde, Petros Nihoyannopoulos, John T . Parissis, Burkert Pieske, Jillian P. Riley, Giuseppe M. C. Rosano, Luis M. Ruilope, Frank Ruschitzka, Frans H. Rutten, Peter van der Meer
Published 2017-02-01

Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study

by Jasper Tromp, MD, Sahiddah Bamadhaj, BSc, John G F Cleland, ProfMD, Christiane E Angermann, ProfMD, Ulf Dahlstrom, ProfMD, Wouter Ouwerkerk, PhD, Wan Ting Tay, MSc, Kenneth Dickstein, ProfMD, Georg Ertl, ProfMD, Mahmoud Hassanein, ProfMD, Sergio V Perrone, ProfMD, Mathieu Ghadanfar, MD, Anja Schweizer, PhD, Achim Obergfell, MD, Carolyn S P Lam, ProfMBBS, Gerasimos Filippatos, ProfMD, Sean P Collins, ProfMD
Published 2020-03-01